Working Knowledge
Business Research for Business Leaders
Filter Results: (189) Arrow Down

HealthRemove Health →

New research on health from Harvard Business School faculty on issues including corporate wellness, investing in community health, and health insurance.
Page 1 of 189 Results →

Curbing an Unlikely Culprit of Rising Drug Prices: Pharmaceutical Donations

by Ben Rand

Policymakers of every leaning have vowed to rein in prescription drug costs, with little success. But research by Leemore Dafny shows how closing a loophole on drugmaker donations could eliminate one driver of rising expenses.

Can Amazon Remake Health Care?

by Christina Pazzanese, Harvard Gazette

Amazon has disrupted everything from grocery shopping to cloud computing, but can it transform health care with its One Medical acquisition? Amitabh Chandra discusses company's track record in health care and the challenges it might face.

Why Cutting Jobless Aid Isn't the Answer to Worker Shortages

by Rachel Layne

Many policymakers thought that halting COVID-related unemployment insurance would be a "silver bullet" to addressing worker shortages. In reality, cutting aid undermined consumer spending, says research by Raymond Kluender. Open for comment; 0 Comments.

Lessons from COVID-19: The Business Skills Doctors Need

by Michael Blanding

The pandemic forced many physicians to become supply chain experts and strategic planners. Robert Huckman and colleagues offer a roadmap for teaching doctors the management and leadership skills they need—before the next public health crisis. Open for comment; 0 Comments.

France Telecom: Corporate Restructuring and Employee Well-Being

Re: Cynthia A. Montgomery & Ashley V. Whillans

The France Telecom case series follows the evolution of the organization from a national telephone monopoly to a private company facing severe challenges. These included a lessening competitive advantage, with the advent of mobile carriers and competition from other countries, as well as a workforce that was much larger than needed and included many civil servants, making it difficult to reduce headcount. As increasing pressure mounted internally to make changes and 22,000 jobs were lost between 2006 and 2009, the culture at France Telecom shifted from one where employees were proud to work to one where the physical and mental wellbeing of some employees became increasingly fragile. Did corporate leaders push employees too far, creating unacceptable levels of stress and unhappiness? Professors Cynthia Montgomery and Ashley Whillans discuss some fundamental tensions between the pressures and benefits of capitalism, the responsibilities of management, and the day-to-day and long-term impacts on employee well-being in the case, “France Telecom: A Difficult Restructuring.” Open for comment; 0 Comments.

Want to Prevent the Next Hospital Bed Crisis? Enlist the SEC

by Regina Herzlinger and Richard Boxer

After two years of COVID-19, many hospitals still haven't figured out how to manage the overwhelming wave of patients that flood ICUs during each surge. Regina Herzlinger and Richard Boxer offer a novel solution. Open for comment; 0 Comments.

Can Mass General Brigham Diversify Its Community of Innovators?

Re: Katherine B. Coffman

In November 2019, Mass General Brigham (MGB) was the largest recipient of National Institutes of Health funding in the world. The Innovation Office, led by Chief Innovation Officer Chris Coburn, sought to capitalize on that funding – with the goal of commercializing research done at the hospital to generate revenue and improve patient care. But CEO Anne Klibanski and other key stakeholders had a serious concern: although women comprised approximately 40 percent of the medical researchers and physicians at MGB, the percentage of women participating in innovation activities lagged behind. Associate Professor Katie Coffman, Coburn, and MGB’s managing director of administration and strategy Diana Schwartzstein discuss how they identify the main sources of the disparities and find the right strategy to expand and diversify MGB’s community of innovators in the case, “Inclusive Innovation at Mass General Brigham.” Open for comment; 0 Comments.

Why COVID-19 Probably Killed More People Than We Realize

by Michael Blanding

Millions of people around the world have died from COVID-19, according to government records, but research by Ethan Rouen, George Serafeim, and Botir Kobilov suggests that the actual number could be much higher. Open for comment; 0 Comments.

A Rare Find in Health Care: A Simple Solution to Racial Inequity

by Michael Blanding

Research by Amitabh Chandra offers a stark new explanation for racial disparities in heart attack survival rates—a problem with immediate answers. Open for comment; 0 Comments.

Kidney Exchange: An Operations Perspective

by Itai Ashlagi and Alvin E. Roth

Kidney exchange has become a standard form of transplantation in the United States and a few other countries in part because of exchange process improvements. However, much more needs to be done: There are still many more patients in need of transplants than can be saved.

How to Learn from the Big Mistake You Almost Make

by Kristen Senz

A brush with disaster can lead to important innovations, but only if employees have the psychological safety to reflect on these close calls, says research by Amy C. Edmondson, Olivia Jung, and colleagues. Open for comment; 0 Comments.

The Health Costs of Cost-Sharing

by Amitabh Chandra, Evan Flack, and Ziad Obermeyer

Small increases in cost cause patients to reduce their use of drugs with major benefits, ultimately causing their death. Since patient cost-sharing introduces large and deadly distortions into the cost-benefit calculus, payers should evaluate the merits of policies in light of their impact on health, not just on health care costs.

Private and Social Returns to R&D: Drug Development and Demographics

by Efraim Benmelech, Janice Eberly, Dimitris Papanikolaou, and Joshua Krieger

Research and development (R&D) by pharmaceutical firms focuses disproportionately on medical conditions afflicting the elderly. The proportion of R&D spending targeting older age groups is increasing over time. Even though these investments in R&D prolong life expectancy and improve quality of life, they have little effect on measured productivity and output growth.

How Influencers, Celebrities, and FOMO Can Win Over Vaccine Skeptics

by Rohit Deshpandé, Ofer Mintz, and Imran S. Currim

Drawing from product innovation theory, Rohit Deshpandé and colleagues offer three recommendations to speed adoption of COVID-19 vaccines. Open for comment; 0 Comments.

Unexpected Exercise Advice for the Super Busy: Ditch the Rigid Routine

by Danielle Kost

Itching to get off the COVID couch? New research by John Beshears bucks conventional wisdom about what it takes to make exercise a habit. Open for comment; 0 Comments.

Hospital Allocation and Racial Disparities in Health Care

by Amitabh Chandra, Pragya Kakani, and Adam Sacarny

Black Americans experience disparities in health outcomes in the United States relative to other demographic groups. This study of heart attack sufferers over two decades develops a framework to examine the allocation of health care and the effectiveness of medical treatments, including beta-blockers and other technologies.

What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?

by Danielle Kost

Even in the best of times, pharmaceutical regulators tend to rush through drug applications in December. Now add in a ruthless pandemic. Research and insights from Lauren Cohen. Open for comment; 0 Comments.

Evaluating Innovative Health Care Solutions for Obesity

Re: Regina E. Herzlinger

From Weight Watchers to bariatric surgery, innovations for combatting obesity abound. But which will do the most good for society and yield the best business results? Professor Regina Herzlinger discusses a new case study. Open for comment; 0 Comments.

The COVID Gender Gap: Why Fewer Women Are Dying

by Dina Gerdeman

To promote the greatest safety, public health officials should target their pandemic messaging to men differently than to women. Research by Vincent Pons and colleagues. Open for comment; 0 Comments.

Older People Are Less Pessimistic about the Health Risks of COVID-19

by Pedro Bordalo, Katherine B. Coffman, Nicola Gennaioli, and Andrei Shleifer

The pandemic presents a unique opportunity to investigate formation of beliefs about an unprecedented, widespread, and life-threatening event. One finding: COVID-19 makes the prospect of disease and death particularly salient for the young.